Biopharmaceutical company.
FY 2014 House and Senate Budget Resolutions as they relate to Medicare savings. Education and outreach about the competitive elements of the Medicare Part D drug benefit and opposition to legislation imposing Medicaid style manufacturer rebates in the program. "Safe Prescribing Act of 2013".

Federal legislative efforts to enhance the security and integrity of the domestic pharmaceutical distribution system.
BUD - Budget/Appropriations MMM - Medicare/Medicaid HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
W STRATEGIES, LLC
1455 Pennsylvania Avenue, NW, Suite 400, Washington, DC, 20004, US
DARREN WILLCOX DARREN WILLCOX DARREN WILLCOX